You are here

  • Home
  • Archive
  • Volume 7, Issue 2
  • Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

Article metrics

Article menu

Download PDFPDF

XML
Rheumatoid arthritis
Original research
Tocilizumab decreases T cells but not macrophages in the synovium of patients with rheumatoid arthritis while it increases the levels of serum interleukin-6 and RANKL

 

Online download statistics by month:

Online download statistics by month: June 2021 to March 2024

AbstractFullPdf
Jun 2021545539126
Jul 202118718452
Aug 2021807727
Sep 2021605734
Oct 2021686568
Nov 2021545026
Dec 2021292814
Jan 2022373213
Feb 2022464720
Mar 2022474016
Apr 2022403817
May 2022484324
Jun 2022383911
Jul 2022494913
Aug 2022737324
Sep 2022535416
Oct 2022525417
Nov 2022434515
Dec 202222229
Jan 2023333223
Feb 2023464720
Mar 202325256
Apr 2023292913
May 2023161822
Jun 202316134
Jul 202315127
Aug 2023533
Sep 202334328
Oct 2023403418
Nov 2023232513
Dec 202323227
Jan 2024222518
Feb 2024252514
Mar 2024212132
Total19441899750